IGFBP7 and acute kidney injury: We aimed (1) to examine whether concentrations of these biomarkers vary with age, body weight, and illness severity as assessed by the pediatric risk of mortality III (PRISM III) score, as well as with kidney function as assessed by estimated glomerular filtration rate (eGFR) in critically ill children, (2) to determine the association between these biomarkers and AKI, and (3) to evaluate whether serum and urinary FGF23 and IGFBP-7 could serve as early predictors of AKI, independently of potential confounders, in critically ill children.